The impact of multimodal forms of art therapy on treatment outcomes and quality of life in Parkinson’s disease
Objective: Assessing the impact of art therapy on treatment outcomes and quality of life in Parkinson's disease (PD). Background: In addition to medical treatment, art…Clinical benefit of Opicapone in patients with different Parkinson disease phenopytes. The OPTIMO study
Objective: To assess the clinical benefit induced by opicapone (OPC) as an add-on therapy to levodopa in fluctuating Parkinson’s disease (PD) patients with special focus…Carbidopa does not cause changes in QTc interval even at a supratherapeutic dose
Objective: To assess the cardiac safety of a single supratherapeutic dose of carbidopa in healthy adults. Background: Carbidopa has been approved for use in combination…Buspirone/zolmitriptan combination exerts synergistic reduction in dyskinesia without worsening Parkinson disease motor symptomatology
Objective: Levodopa-induced dyskinesias (LID) may be amenable to interventions with striatal serotonergic receptors. Preclinical evidence suggests that co-administration of serotonergic agonists with selective receptor properties…Peri-Electrode Edema after Deep Brain Stimulation Implantation – Case Report and Literature Review
Objective: To report a case of peri-electrode edema after Deep Brain Stimulation (DBS), and discuss its main aspects. Background: PD is a neurodegenerative condition, and…Exercise-induced angiogenesis and midbrain neuroprotection in a mouse model of experimental PD
Objective: The goal of this study is to characterize microvascular changes in the SNpc in response to a neuroprotective bout of exercise. Background: Parkinson’s disease…Identification of Pre-Diagnostic Biomarkers for Parkinson’s Disease from Plasma Proteome
Objective: To identify pre-diagnostic biomarkers for Parkinson’s Disease (PD) from the plasma proteome. Background: The plasma proteome is a non-invasive and accessible measure to assess…Mitochondrial Complex I Brain Imaging in Parkinson’s Disease and Lewy Body Dementia
Objective: To compare brain mitochondrial respiratory Complex-1 (mito-C1) between Parkinson’s disease (PD) and PD dementia/Dementia with Lewy Bodies (PDD/DLB) participants and unimpaired controls, using 18F-BCPP-EF,…Motion-robust high-resolution imaging of nigrosome-1 in Parkinson’s disease
Objective: To develop a motion-insensitive high-resolution susceptibility weighted imaging (SWI) sequence for evaluating nigrosome-1 in substantia nigra. Background: In Parkinson's disease (PD) increased amounts of…Classification of Parkinson’s disease using AI based on multi-modal brain MRI connectomics
Objective: To develop a novel artificial intelligence (AI) model using connectivity matrices derived from multi-modal brain magnetic resonance imaging (MRI) to aid diagnosis and subtyping…
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 338
- Next Page »